Enhanced IL-6 trans-signaling is observed in chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, inflammatory bowel disease, and other autoimmune diseases [42]. This evidence concerns the gene IL6 and inflammatory bowel disease.